Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
2.110
+0.260 (14.05%)
At close: Apr 10, 2026, 4:00 PM EDT
2.000
-0.110 (-5.21%)
After-hours: Apr 10, 2026, 7:57 PM EDT
Indaptus Therapeutics Market Cap
Indaptus Therapeutics has a market cap or net worth of $4.73 million as of April 10, 2026. Its market cap has decreased by -48.17% in one year.
Market Cap
4.73M
Enterprise Value
-3.78M
1-Year Change
-48.17%
Ranking
Category
Stock Price
$2.11
Market Cap Chart
Since August 4, 2021, Indaptus Therapeutics's market cap has decreased from $47.95M to $4.73M, a decrease of -90.13%. That is a compound annual growth rate of -39.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 4.73M | -7.15% |
| Dec 31, 2025 | 5.10M | -49.63% |
| Dec 31, 2024 | 10.12M | -31.58% |
| Dec 29, 2023 | 14.79M | 21.38% |
| Dec 30, 2022 | 12.18M | -73.92% |
| Dec 31, 2021 | 46.70M | -2.60% |
| Aug 4, 2021 | 47.95M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jaguar Health | 4.71M |
| Pulmatrix | 4.60M |
| 60 Degrees Pharmaceuticals | 4.59M |
| Revelation Biosciences | 4.58M |
| Ensysce Biosciences | 4.49M |
| Akari Therapeutics, | 4.31M |
| AIM ImmunoTech | 4.22M |
| VivoSim Labs | 3.99M |